GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

HealthWarehouse.com HEWA · USD

Consumer Discretionary · US listing · 🇺🇸 United States

Compare

0.09

0.00%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$49.0m

FY2015FY2025

Net income

$264,707

FY2015FY2025

Free cash flow

$1.1m

FY2015FY2025

Shareholders' equity

−$3.3m

FY2015FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2018FY2017FY2016FY2015
Revenue$49.0m$33.6m$20.3m$18.1m$16.1m$17.2m$15.7m$14.8m$10.4m$7.0m
Operating income$411,626−$92,760−$1.6m−$784,082−$359,618−$49,124−$377,570$478,006−$1.3m−$529,909
Net income$264,707−$332,974−$1.8m−$952,029−$572,502$641,326−$817,054$371,775−$1.4m−$626,682
Diluted earnings per share0.00-0.01-0.03-0.02-0.010.01-0.020.01-0.03-0.02

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2018FY2017FY2016FY2015
Total assets$5.9m$5.0m$3.2m$4.0m$3.6m$3.3m$2.0m$1.6m$975,165$966,107
Cash and short-term investments————————$247,083$156,305
Total liabilities$9.2m$9.1m$7.2m$7.0m$6.4m$6.0m$5.8m$4.7m$5.2m$4.8m
Debt$2.1m$2.2m$2.0m$2.2m$2.1m$2.1m$2.5m$1.8m$1.4m$1.0m
Shareholders' equity−$3.3m−$4.0m−$4.0m−$3.0m−$2.8m−$2.7m−$3.7m−$3.1m−$4.3m−$3.9m
Shares outstanding57m56m54m54m52m52m49m43m43m—

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2018FY2017FY2016FY2015
Cash from operations$1.2m$705,264−$163,837−$624,453$400,506$250,869—−$580,768−$116,830−$548,281
Capital spending−$95,228−$84,904−$309,970−$512,851−$86,861−$10,080—−$33,254−$9,703−$6,331
Free cash flow$1.1m$620,360−$473,807−$1.1m$313,645$240,789—−$614,022−$126,533−$554,612

Latest quarters

By quarter end

Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024
Revenue$6.3m$9.9m$8.4m$15.7m$15.0m$13.7m$9.0m$5.8m
Operating income−$312,217−$108,932−$61,482$318,705$263,335$215,856$137,680−$268,640
Net income−$360,713−$68,952−$71,871$227,672$177,858$189,161$73,785−$343,508
Diluted earnings per share-0.01-0.00-0.000.000.000.000.00-0.01
Cash from operations——$1.0m−$4.0m$5.0m———
Total assets$4.8m$5.9m$8.0m$6.2m$15.0m$5.0m$3.7m$3.4m
Debt$2.1m$2.1m——$2.2m$2.2m$2.2m—
Shareholders' equity−$3.6m−$3.3m−$3.5m−$3.5m−$3.8m−$4.0m−$4.3m−$4.4m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue39.3%23.3%21.4%
Net income—-16.2%—

Average margins

Over each period

1 year3 years5 years10 years
Operating margin0.4%-1.7%-1.6%—
Net margin-0.1%-2.3%-1.8%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2018FY2017FY2016FY2015
Price to earnings23.6-13.4-4.3-10.8-13.612.1-5.216.7-2.8-3.1
Price to sales0.10.10.40.60.50.50.30.40.40.3

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return50%-38%-13%-6%-6%209%-32%-32%23%88%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 20-to-1 reverse split · 29 Jul 2010

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.